Correction to: Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy (Annals of Hematology, (2025), 104, 10, (5223-5236), 10.1007/s00277-025-06602-9)

Simple item page
dc.contributor.authorJiang B.
dc.contributor.authorLi J.
dc.contributor.authorLiu L.
dc.contributor.authorDu X.
dc.contributor.authorJiang H.
dc.contributor.authorHu J.
dc.contributor.authorZeng X.
dc.contributor.authorSakatani T.
dc.contributor.authorKosako M.
dc.contributor.authorDeng Y.
dc.contributor.authorIvanov V.
dc.contributor.authorBondarenko S.
dc.contributor.authorLee L.W.L.
dc.contributor.authorKhuhapinant A.
dc.contributor.authorMartynova E.
dc.contributor.authorHasabou N.
dc.contributor.authorAn J.J.H.
dc.contributor.authorWang J.
dc.contributor.correspondenceJiang B.
dc.contributor.otherMahidol University
dc.date.accessioned2026-02-19T18:28:32Z
dc.date.available2026-02-19T18:28:32Z
dc.date.issued2026-03-01
dc.description.abstractIn the published paper, the median event-free survival of the gilteritinib arm was incorrectly presented in Fig. 4. The median value ‘21’ should be presented as ‘2.1’. The original article has been corrected.
dc.identifier.citationAnnals of Hematology Vol.105 No.3 (2026)
dc.identifier.doi10.1007/s00277-026-06880-x
dc.identifier.eissn14320584
dc.identifier.issn09395555
dc.identifier.scopus2-s2.0-105029868499
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/115166
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleCorrection to: Continous or fixedcarfilzomib, lenalidomide and dexamethasone (krd) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life surveyfrom European myeloma network (emn) Italy (Annals of Hematology, (2025), 104, 10, (5223-5236), 10.1007/s00277-025-06602-9)
dc.typeErratum
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105029868499&origin=inward
oaire.citation.issue3
oaire.citation.titleAnnals of Hematology
oaire.citation.volume105
oairecerif.author.affiliationFujian Medical University
oairecerif.author.affiliationPeking Union Medical College Hospital
oairecerif.author.affiliationPeking University People's Hospital
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationGuangdong Provincial People’s Hospital of Southern Medical University
oairecerif.author.affiliationAstellas Pharma Inc., Japan
oairecerif.author.affiliationInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
oairecerif.author.affiliationAlmazov National Medical Research Centre
oairecerif.author.affiliationTongren Hospital Shanghai Jiao Tong University School Of Medicine
oairecerif.author.affiliationPeking University International Hospital
oairecerif.author.affiliationAstellas Pharma US, Inc.
oairecerif.author.affiliationLtd.
oairecerif.author.affiliationPavlov University
oairecerif.author.affiliationKrasnoyarsk Regional Clinical Hospital
oairecerif.author.affiliationQueen Elizabeth Hospital

Files

Collections

Scopus 2026